Friday, 18 July 2025
  
Login

Australia's most trusted
source of pharma news

Friday, 18 July 2025
Ascott
Ascott
Why this workplace is so great

This pharma has landed a Great Place to Work certification in Australia and New Zealand for the fourth consecutive year, reflecting its commitment to fostering an environment that unlocks the potential of its employees.

New GM resigns before start date
ICYMI: Why this country leader bowed out ahead of his arrival in Australia and the other most popular stories this week
TODAY Your Week in 5 Minutes
Jobs up for grabs on Aussie team
Company expands with a focus on filling commercial roles to meet demand in this rapidly growing space
TODAY
What's driving burnout in pharma?
Hidden drivers that push some to potentially dangerous work levels with few boundaries around workload and hours
17 July
$924M blockbusters under threat
In just a matter of weeks Amgen, Johnson & Johnson, and Novartis could each face their first rivals on the PBS
16 July
Big pay, top perks... but still quitting
Why Australian pharma is losing some of its best people with leadership and company culture in the firing line
15 July
Incoming GM quits before Day One
Change of plan as this newly named Australian-based General Manager, announces his departure from the company
14 July
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (3)

Sales & Customer Relations (15)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (4)

Devices (1)

Executive Roles (2)

Other (17)

Why this CEO can't help smiling
After a 42 per cent sales slump on a top-selling blockbuster which has lost patent exclusivity, J&J just pulled off an amazing feat
TODAY
Rare disease drug changes hands
Treatment available in more than 40 countries, including Australia, set to be taken over by the end of the year
TODAY
Ex-Aussie GM lands new role
Plus other new senior level job appointments across Australian pharma spanning public affairs, legal, HR and more
17 July
Fraudsters target PBS prescriptions
Health Dept sounds the alarm following reports of criminal activity linked to documents containing patient information
17 July
Bayer closes in on Astellas' market
German pharma scores first worldwide approval, with the TGA likely to follow suit in the coming months
17 July
TGA beats FDA to updated label
US approves a new dosing regimen with fewer side effects already used in Australia and it could boost uptake
17 July
Trump tariff talk wipes $24B off ASX
US President names date for introduction of pharmaceutical tariffs, ahead of worst Aussie stock market dive since May
16 July
Aussie manufacturers ink MoU
Australia's leading CDMOs join forces to boost the onshore development and manufacture of advanced therapies
16 July
ADC looks beyond breast cancer
Among two oncology expansions that have recently won the Medical Services Advisory Committee's support
16 July
Blood cancer trial astounds again
Company looks to expand access to more niche indications after an additional two patients achieved a complete response
16 July
TGA leads global drug seizures
Australia's medicines regulator has recorded the largest seizure of illegal pharmaceutical products globally
15 July
First Barbie with diabetes launches
In a move to boost inclusivity, Mattel has released the first Barbie doll with Type 1 diabetes, delighting kids with the condition
15 July
AbbVie pays $2.9B to outdo rivals
Licensing deal struck for first-in-class tri-specific drug for MM which could better rivals currently dominating the space
15 July
GSK campaign draws big names
Olympians join medical experts to warn about the devastating impact of meningococcal disease as peak season hits
15 July
PiF Jobs
PiF Jobs
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.